Cargando…

Structural white matter networks in myotonic dystrophy type 1

The myriad of neuropsychiatric manifestations reported in myotonic dystrophy type 1 may have its origin in alterations of complex brain network interactions at the structural level. In this study, we tested the hypothesis that altered white matter microstructural integrity and network organisation w...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dorst, Maud, Okkersen, Kees, Kessels, Roy P.C., Meijer, Frederick J.A., Monckton, Darren G., van Engelen, Baziel G.M., Tuladhar, Anil M., Raaphorst, Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413352/ https://www.ncbi.nlm.nih.gov/pubmed/30522973 http://dx.doi.org/10.1016/j.nicl.2018.101615

Ejemplares similares

Human brain pathology in myotonic dystrophy type 1: A systematic review
por: Weijs, Ralf, et al.
Publicado: (2021)

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort
por: Cumming, Sarah A., et al.
Publicado: (2019)

Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1
por: Wenninger, Stephan, et al.
Publicado: (2021)

Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy
por: van As, Daniël, et al.
Publicado: (2021)

Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2019)

Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI
por: Heskamp, Linda, et al.
Publicado: (2019)

Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy
por: Tankink, Maurits, et al.
Publicado: (2022)

High disease impact of myotonic dystrophy type 2 on physical and mental functioning
por: Tieleman, Alide A., et al.
Publicado: (2011)

Living with myotonic dystrophy; what can be learned from couples? a qualitative study
por: Cup, Edith HC, et al.
Publicado: (2011)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1
por: Seijger, Charlotte G. W., et al.
Publicado: (2016)

Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2020)

Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial
por: van Engelen, Baziel
Publicado: (2015)

An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2022)

Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
por: Landfeldt, Erik, et al.
Publicado: (2019)

Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
por: van der Plas, Ellen, et al.
Publicado: (2021)

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy
por: González-Barriga, Anchel, et al.
Publicado: (2015)

Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2022)

Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype
por: Joosten, Isis B.T., et al.
Publicado: (2022)

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
por: Kamsteeg, Erik-Jan, et al.
Publicado: (2012)

White matter microstructure relates to motor outcomes in myotonic dystrophy type 1 independently of disease duration and genetic burden
por: Koscik, Timothy R., et al.
Publicado: (2021)

Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1
por: Miller, Jacob N., et al.
Publicado: (2020)

Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1
por: Ausems, Cornelia Rosanne Maria, et al.
Publicado: (2019)

Blood-Based Markers of Neuronal Injury in Adult-Onset Myotonic Dystrophy Type 1
por: van der Plas, Ellen, et al.
Publicado: (2022)

Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)
por: DiPaolo, Giovanni, et al.
Publicado: (2017)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Change over time in ability to perform activities of daily living in myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2020)

Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats
por: van der Plas, Ellen, et al.
Publicado: (2019)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1
por: Miller, Jacob N., et al.
Publicado: (2021)

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
por: Flower, Michael, et al.
Publicado: (2019)

Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy
por: Ausems, C. Rosanne M., et al.
Publicado: (2020)

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
por: Wood, Libby, et al.
Publicado: (2017)

Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy
por: Mul, Karlien, et al.
Publicado: (2020)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Consensus-based care recommendations for adults with myotonic dystrophy type 1
por: Ashizawa, Tetsuo, et al.
Publicado: (2018)

Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations
por: Voermans, N. C., et al.
Publicado: (2019)

CRISPR/Cas9-Induced (CTG⋅CAG)(n) Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
por: van Agtmaal, Ellen L., et al.
Publicado: (2017)

The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1
por: Ballester-Lopez, Alfonsina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c4m5foe2bg8p10bmhfck13hfgb